Your browser doesn't support javascript.
loading
Sodium-glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure.
Karlström, Patric; Pivodic, Aldina; Dahlström, Ulf; Fu, Michael.
Affiliation
  • Karlström P; Department of Internal Medicine, Ryhov County Hospital, SE-551 85, Jönköping, Sweden.
  • Pivodic A; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
  • Dahlström U; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
  • Fu M; Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
ESC Heart Fail ; 11(1): 327-337, 2024 Feb.
Article in En | MEDLINE | ID: mdl-38012065

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Diabetes Mellitus / Heart Failure Limits: Humans Language: En Journal: ESC Heart Fail Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Diabetes Mellitus / Heart Failure Limits: Humans Language: En Journal: ESC Heart Fail Year: 2024 Document type: Article